Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Takeda
Janssen Scientific Affairs, LLC
Pharmacosmos A/S
Martin-Luther-Universität Halle-Wittenberg
Chongqing University Cancer Hospital
Peking University
Takeda
University of Maryland, Baltimore
Shandong Provincial Hospital
Children's Hospital of Michigan
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
University of Miami
H. Lee Moffitt Cancer Center and Research Institute
Peking University
Peking University
Peking University
Peking University
Centre Hospitalier Universitaire, Amiens
Peking University
Peking University
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Sun Yat-sen University
Taipei Veterans General Hospital, Taiwan
King's College Hospital NHS Trust
Johann Wolfgang Goethe University Hospital
PETHEMA Foundation
Sanofi
Mt. Sinai Medical Center, Miami